Triumph Capital Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.63K Hold
250
– – ﹤0.01% 1635
2026
Q2
$2.38K Hold
250
– – ﹤0.01% 1537
2026
Q1
$1.37K Hold
250
– – ﹤0.01% 1586
2025
Q4
$6.6K Buy
+250
New +$4.83K ﹤0.01% 1184

Other funds holding GUTS

Triumph Capital Management's GUTS Position: Q3 2026 in Review

Triumph Capital Management held its Fractyl Health (GUTS) position steady in Q3 2026 at 250 shares worth $1.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1635.

Triumph Capital Management first reported a position in GUTS in Q4 2025 and has held it in 4 quarters since. The position peaked at $6.6K in Q4 2025. 21 funds tracked by Wall St. Rank hold GUTS as of Q3 2026.

  • Triumph Capital Management held 250 shares of Fractyl Health worth $1.63K as of Q3 2026.
  • Triumph Capital Management left its Fractyl Health share count unchanged in Q3 2026.
  • Fractyl Health made up ﹤0.01% of Triumph Capital Management's portfolio in Q3 2026, its #1635 holding.
  • Triumph Capital Management first reported a position in Fractyl Health in Q4 2025 and has held it in 4 quarters since.
  • Triumph Capital Management's Fractyl Health position peaked at $6.6K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Fractyl Health as of Q3 2026.

Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.